Fwd..Time to end Profit Driven Mandatory Vaccination Racket

[Guest guest]

Time to end profit-driven mandatory vaccination racket Posted by: "intruthwetrust" truththatweknow truththatweknow

Wed Feb 20, 2008 3:15 am (PST) Time to end profit-driven mandatory vaccination racketBy Evelyn PringleOnline Journal Contributing WriterFeb 13, 2008, 00:13Email this articlePrinter friendly pageThe push to keep adding more vaccines to the mandatory schedules comes directly from a purely profit motivated industry and a recent investor report estimates that the worldwide market will quadruple from about $4.3 billion in 2006 to more than $16 billion in 2016, with the biggest boost coming from kids in the US.A November 2007 report, entitled "Pipeline and Commercial Insight: Pediatric and Adolescent Vaccines," authored by vaccine analyst, Hedwig Kresse, for the independent market analyst Datamonitor, discusses the future outlook for vaccine profits.The report provides an assessment of products and a patient-based forecast of market size and

coverage rates to the year 2016, and predicts that the introduction of high price vaccines will induce rapid growth in the pediatric and adolescent vaccines market.The report predicts that due to the "promising commercial potential" of new, high-price vaccines, the pediatric and adolescent market will quadruple from approximately $4.3 billion in 2006, to over $16 billion by 2016, across the US, the EU-five including France, Germany, Italy, Spain, and the UK, and Japan.The crucial factor for success in the pediatric market, the report notes, is the introduction of a product into national vaccination schedules. "Along with reimbursement, this virtually guarantees the rapid uptake and continuously high coverage rates in the target population," Ms. Kresse states.As an example, she cites Wyeth’s Prevnar, as the first premium price vaccine launched in the US in 2000 for vaccinating infants against pneumonia and meningitis.Since

then, Prevnar has been added to the childhood vaccination schedules in the US and EU-five despite its high price of nearly $320 for the four-dose regimen. In 2006, Global sales reached almost $2 billion, making Prevnar the first vaccine to attain blockbuster status, according to the report. By 2016, Datamonitor expects the total value of the infant market for pneumococcal vaccines to increase to $2.3 billion.In June 2006, Merck’s Gardasil was approved for cervical cancer. Because it was the first vaccine offered as a preventive measure for a form of cancer, its approval generated tremendous public attention along with pressure for health care providers to make the vaccine available to teenage girls at a cost of $360 for three doses."Although most cases of cervical cancer in the developed world can be prevented through the existing pap smear screening programs, the expensive HPV vaccination has been recommended and is reimbursed for teenage girls

across the US and Europe," Ms. Kresse reports.She notes that this decision is driven more by public pressure and excitement about the opportunity to vaccinate against cancer rather than by real need. The widespread publicity has led to a good uptake in the target group of adolescent girls, which is usually hard to reach for vaccination, Ms. Kresse points out to investors.Datamonitor sees a huge commercial opportunity in HPV vaccines, with annual sales of $1.4 billion, in teenage girls for the seven major markets by 2016 and a cumulative catch-up opportunity in women aged 13-26 that could add up to over $17 billion by 2016.But Ms. Kresse warns investors that the "lack of medical need" for rotavirus vaccines such as RotaTeq will limit their uptake in most markets. RotaTeq is advertised to combat diarrhea that usually affects infants under the age of two, and was introduced by Merck in the US in 2006 at a price of $200 for the

three-dose regimen.According to Ms Kresse, many countries, but not the US, have refused to add the vaccine to their schedules due to cost-benefit reasons. “In the developed world, rotavirus diarrhea is rarely severe for small infants and quick and efficacious treatment is already available," she writes. "Consequently, healthcare authorities see no need to widely introduce a very expensive vaccine.”Datamonitor estimates that annual sales will remain limited to approximately $1 billion across the seven major markets by 2016 and predicts that the US will account for the majority of sales, being the only country to have recommended the rotavirus vaccine for all infants.Wyeth's Prevnar vaccine came on the market in 2000 and is recommended for children under 2. The vaccine was hailed as a breakthrough and had sales of more than $1.5 billion in 2006. Prevnar is given as four shots to children between 2 and 15 months.On September 18,

2007, NewsMax reported that the vaccine has dramatically curbed pneumonia and other serious illnesses in children but is also having an unfortunate effect: "promoting new superbugs that cause ear infections."According to NewsMax, doctors reported finding the first such germ that is resistant to all drugs approved to treat childhood ear infections and nine toddlers in Rochester, N.Y., have had the bug and that it also may be turning up elsewhere.It is a strain of strep bacteria not included in the pneumococcal vaccine. Prevnar prevents seven strains responsible for most cases of pneumonia, meningitis and bloodstream infections. But dozens more strains exist and some have become resistant to antibiotics since the vaccine combats the more common strains.If the new strains continue to spread, "it tells us the vaccine is becoming less effective" and needs to be revised, Dr Dennis Maki, infectious diseases chief at the University of

Wisconsin-Madison Hospitals and Clinics, told NewsMax.A new study in the November 8, 2007, New England Journal of Medicine by researchers at Oregon Health & Science University, supported by the United States Public Health Service, suggests that the schedule for vaccinating and revaccinating against diseases should be reevaluated and adjusted.The study found that in many cases, the established duration of immunity for vaccines is greatly underestimated, which means that people are getting booster shots when their immunity levels do not require it and those antibody responses caused by viruses such as measles mumps, and rubella remained at protective levels for several decades and in most cases, for life.The research also reconfirmed a previous finding by Slifka and his colleagues: that the duration of immunity after smallpox vaccination is much longer than previously thought. In that earlier study published in the journal Nature

Medicine in 2003, these OHSU researchers observed surprisingly long-lived antiviral antibody responses but they were unable to measure the slow rate of decline.The study indicates that the duration of immunity after smallpox vaccination is maintained with a calculated half-life of 92 years and that a person who has received the primary series of tetanus vaccine is likely to be protected for three decades.Experts say we have allowed ourselves and our children to be overdosed through a culture dominated by industry marketing influence which has now become dangerously out of control and detrimental to our children's health. "In the 21st century, it is unacceptable to be marketing medication to infants and children that may not work," Dr Steven Czinn, chair of the department of pediatrics at the University of Maryland School of Medicine, told Reuters on October 11, 2007.In the November 19, 2007, Huffington Post article, "Over Medicated and

Over-Vaccinated: The Unintended Consequence of Medicines Meant to Protect," Deirdre Imus asks, "Where are the conflict-free studies that prove giving infants and children 49 immunizations -- most of them by age 5, are safe and effective?"She points out that studies have provided evidence that the over-vaccination of dogs and cats can result in numerous maladies including cancer, skin and ear conditions, arthritis, allergies, diabetes, aggression, behavior problems and other immune system dysfunctions. "There is even a name for the conditions caused by animal over-vaccination, vaccinosis," she notes.Ms Imus also points out that the mercury-containing preservative, thimerosal, used in vaccines for over 50 years was removed from animal vaccines in 1992."Unfortunately for the kids," she writes, "it remained in children's vaccines for another decade and remains in some vaccines like the influenza (25 micrograms) and tetanus vaccine (25

micrograms) today and in trace amounts (3 micrograms) in some immunizations. "She says what most people do not realize is that any liquid waste containing more than 200 parts per billion (ppb) mercury must be deposited at a hazardous waste site and that drinking water cannot exceed 2 ppb mercury."But when the influenza vaccines arrive and are injected into pregnant woman and infants as young as six months, those vaccines contain 50,000 ppb mercury," Ms Imus notes.This amount of mercury is 250 times higher than hazardous waste, she notes, and, according to EPA guidelines, this amount can only be considered safe if a person weighs 550 pounds. "Even trace amounts of mercury in vaccines can be anywhere from 600 to 2000 ppb," she warns.More- http://onlinejourna l.com/artman/ publish/article_

2947.shtmlClick to join catapultthepropagan da http://groups. / group/catapultth epropaganda/ joinClick to join openmindopencodenew s http://groups. / group/openmindop encodenews/ joinHealthLatest HeadlinesTime to end profit-driven mandatory vaccination racket For-profit health care: More than one way to scan a CAT Accused of hiding drug dangers again, Big Pharma starts 2008 defending itself Medical researchers patented AIDS cure in 1990 The polio vaccine, AIDS, and their US-made viruses Inside Bush's FDA: A perpetual leaker of insider information and the slipshod testing of generic drugs So . . . what's this here single-payer

health care thing all about anyway? AIDS estimates surge in America Teenage girl dies so CIGNA execs can get richer Drugs not hugs, say pharma linked child psychiatrists Medicare Part D destroys the lives of senior citizens, the poor, and the sick Eli Lilly's latest curse: Cymbalta FDA, industry insiders derail approval of new cancer treatments The topic of cancer Why Bush should have signed the children’s health act S-CHIP veto: The millstone around Bush's neck Canada unveils mental health board:Prime Minister Harper’s cure worse than disease Setting the record straight: observations on universal health care from actual Canadians Avandia's real warning should be about the FDA and Big Pharma symbiosis AMA sics drug salesmen on doctors, charge groups at annual meetingFront Page Donate Submissions Announcements NewsLinks Special Reports News Media Elections & Voting Health Religion Social Security Analysis Commentary Editors' Blog Reclaiming America The

Splendid Failure of Occupation The Lighter Side Reviews The Mailbag Online Journal Stores Official Merchandise Amazon.com Links Join Mailing List Search [input] [input] All Categories DonateSubmissionsAn nouncementsNewsL inksSpecial ReportsNews MediaElections & VotingHealthReligio nSocial SecurityAnalysisCom mentaryEditors' BlogReclaiming AmericaThe Splendid Failure of OccupationThe Lighter SideReviewsThe MailbagOnline Journal Stores Official Merchandise Amazon.comLinksJoin Mailing ListAdvanced SearchReach out and touch someone with your Love & Gratitude.. ~Ashok

Do you get hundreds of mails everyday? Delete none. Keep them all.